title: Folinic acid supplements to pyrimethamine-sulfadiazine for Toxoplasma encephalitis are associated with better outcome.
authors.forename: C
authors.initials: C
authors.lastname: Van Delden
authors.forename: B
authors.initials: B
authors.lastname: Hirschel
mesh_terms: D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D004660:Encephalitis / Q000188:drug therapy*; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use*; D011739:Pyrimethamine / Q000627:therapeutic use*; D012189:Retrospective Studies; D013411:Sulfadiazine / Q000627:therapeutic use*; D016781:Toxoplasmosis, Cerebral / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000981:Antiprotozoal Agents; D004338:Drug Combinations; D013411:Sulfadiazine; D002955:Leucovorin; D011739:Pyrimethamine